Cargando…
Blood biomarker for Parkinson disease: peptoids
Parkinson disease (PD) is the second most common neurodegenerative disease. Because dopaminergic neuronal loss begins years before motor symptoms appear, a biomarker for the early identification of the disease is critical for the study of putative neuroprotective therapies. Brain imaging of the nigr...
Autores principales: | Yazdani, Umar, Zaman, Sayed, Hynan, Linda S, Brown, L Steven, Dewey, Richard B, Karp, David, German, Dwight C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088434/ https://www.ncbi.nlm.nih.gov/pubmed/27812535 http://dx.doi.org/10.1038/npjparkd.2016.12 |
Ejemplares similares
-
A Search for Blood Biomarkers for Autism: Peptoids
por: Zaman, Sayed, et al.
Publicado: (2016) -
Antibody biomarker for de novo Parkinson disease: attempted validation
por: Feng, Na, et al.
Publicado: (2018) -
Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder
por: Singh, Sarika, et al.
Publicado: (2017) -
Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer’s Disease in Blood
por: Guo, Yuxin, et al.
Publicado: (2021) -
Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood
por: Guo, Yuxin, et al.
Publicado: (2022)